← Back to all trials
Recruiting
NCT07538388
Continuous Versus Bolus Norepinephrine Administration to Treat Postinduction Hypotension
Conditions: Postinduction Hypotension
Sex: All
Ages: 45 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 446
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Location: Department of Anesthesiology, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf Düsseldorf
Summary
INDUCT-Multi is a multicenter randomized trial investigating whether continuous, compared to bolus, administration of norepinephrine during induction of general anesthesia reduces postinduction hypotension in high-risk non-cardiac surgery patients.
Eligibility Criteria
Inclusion Criteria:
We will include consenting patients ≥45 years scheduled for elective major non-cardiac surgery under general anesthesia with planned continuous intra-arterial blood pressure monitoring with a radial arterial catheter and with at least two of the following risk criteria for developing acute kidney injury:
* Age ≥65 years
* ASA physical status III or IV
* Chronic arterial hypertension
* Diabetes mellitus requiring medication
* Intra-abdominal surgery
* Preoperative renal insufficiency (serum creatinine ≥1.2 mg/dL)
Exclusion Criteria:
* Pregnancy
* Cardiac arrhythmia
* History of intracranial hemorrhage or intracranial aneurysm
* Clinical indication for continuous norepinephrine infusion during induction of general anesthesia (e.g., severe aortic valve stenosis, coronary artery disease, or heart failure)
* Patients who are unable to understand, read, and provide informed consent in German
Source: ClinicalTrials.gov (NCT07538388). StuddyBuddy aggregates publicly available trial information.
